Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$37.32 - $49.29 $79,827 - $105,431
-2,139 Reduced 22.52%
7,361 $277,000
Q2 2023

Aug 04, 2023

BUY
$39.98 - $47.68 $20,389 - $24,316
510 Added 5.67%
9,500 $432,000
Q1 2023

Apr 19, 2023

BUY
$37.58 - $52.57 $8,906 - $12,459
237 Added 2.71%
8,990 $364,000
Q4 2022

Jan 23, 2023

BUY
$49.7 - $57.71 $12,623 - $14,658
254 Added 2.99%
8,753 $0
Q3 2022

Oct 13, 2022

BUY
$53.86 - $66.8 $6,247 - $7,748
116 Added 1.38%
8,499 $458,000
Q2 2022

Aug 02, 2022

BUY
$63.83 - $80.0 $74,808 - $93,760
1,172 Added 16.25%
8,383 $538,000
Q2 2022

Jul 13, 2022

SELL
$63.83 - $80.0 $43,468 - $54,480
-681 Reduced 8.63%
7,211 $580,000
Q1 2022

Apr 11, 2022

BUY
$76.85 - $89.45 $7,070 - $8,229
92 Added 1.18%
7,892 $612,000
Q4 2021

Jan 21, 2022

BUY
$74.57 - $87.19 $43,921 - $51,354
589 Added 8.17%
7,800 $670,000
Q2 2021

Jul 16, 2021

BUY
$80.5 - $88.01 $40,250 - $44,005
500 Added 7.45%
7,211 $580,000
Q4 2020

Feb 08, 2021

SELL
$75.39 - $82.36 $61,065 - $66,711
-810 Reduced 10.77%
6,711 $538,000
Q1 2020

May 08, 2020

SELL
$71.57 - $93.3 $6,799 - $8,863
-95 Reduced 1.25%
7,521 $611,000
Q2 2019

Jul 24, 2019

BUY
$73.44 - $82.41 $36,720 - $41,205
500 Added 7.03%
7,616 $624,000
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $58,032 - $73,179
900 Added 14.48%
7,116 $579,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $186,193 - $235,734
3,030 Added 95.1%
6,216 $409,000
Q3 2018

Nov 27, 2018

SELL
$70.71 - $77.75 $132,086 - $145,237
-1,868 Reduced 36.96%
3,186 $212,000
Q2 2018

Aug 16, 2018

BUY
$63.43 - $75.41 $5,898 - $7,013
93 Added 1.87%
5,054 $357,000
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $2,703 - $2,906
44 Added 0.89%
4,961 $325,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,917
4,917 $296,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.